Skip to main content

Table 1 Baseline patient demographics

From: Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: a retrospective cohort study in 265 patients

 

Procedure type

 
 

Hip

(n = 151)

Knee

(n = 114)

Total

(n = 265)

Female - no (%)

88 (58.2)

80 (70.4)

169 (63.5)

Age (years)

 Mean

66

70

68

 Range

32–91

47–90

32–91

Height (cm)

 Mean

167.9

163.2

165.8

 Range

131.0–193.0

143.0–187.0

131.0–193.0

Weight (kg)

 Mean

79.4

80.8

80.0

 Range

44.7–120.5

45.4–140.0

44.7–140.0

BMI (kg/m2)

 Mean

28.1

30.2

29.0

 Range

17.2–46.2

19.7–47.9

17.2–47.9

Operation type - no (%)

 Primary

146 (96.7)

106 (93.0)

253 (95.1)

 Revision

5 (3.3)

8 (7.0)

13 (4.9)

Fixation technique

 Cemented

35 (23.2)

110 (96.5)

146 (54.9)

 Hybrid

50 (33.1)

0 (0.0)

50 (18.8)

 Uncemented

66 (43.7)

3 (2.6)

69 (25.9)

 Unknown

0 (0.0)

1 (0.9)

1 (0.4)

Operation duration

 Mean

1.9

2.2

2.03

 Range

1.0–2.8

0.5–6.5

1.0–6.5

Comorbidities

 Chronic kidney disease

3 (2.0)

2 (1.8)

5 (1.9)

 Hepatic failure

1 (0.7)

2 (1.8)

3 (1.1)

 Diabetes Mellitus

12 (7.9)

17 (15.7)

29 (10.9)

 IHD

8 (5.3)

8 (7.0)

16 (6.0)

 Asthma/COPD

22 (14.6)

16 (13.9)

38 (14.3)

 Hypertension

49 (32.5)

64 (55.7)

113 (42.6)

 Atrial Fibrillation

5 (3.3)

4 (3.5)

9 (3.4)

 Previous VTE

2 (1.3)

3 (3.5)

6 (2.3)

 Vascular disease

2 (1.3)

1 (0.9)

3 (1.1)

 Congestive Cardiac Failure

0 (0.0)

0 (0.0)

0 (0.0)

Total duration of prophylaxis (days)

 Mean

31–45

6–33

 

 Range

31–45

6–33